Selected Publications

Anderson C, Wu J, Viteri B, Guay-Woodford LM, Cadnapaphornchai MA : New insights about kidney length in pediatric ADPKD: Cross-sectional analysis of a single-center cohort. Poster presentation, American Society of Nephrology Kidney Week 2025, Houston TX November 2025.

Cadnapaphornchai MA, Dell KM, Gimpel C, Guay-Woodford LM, Gulati A, Hartung EA, Liebau MC, Mallett AJ, Marlais M, Mekahli D, Piccirilli A, Seeman T, Tindal K, Winyard PJD: Polycystic kidney disease in children: The current status and the next horizon. Am J Kidney Dis 86(3): 383-92, Sep 2025.

Kidney Disease: Improving Global Outcomes (KDIGO) ADPKD Work Group: Devuyst O, Ahn C, Barten TRM, Brosnahan B, Cadnapaphornchai MA, Chapman AB, Cornec-Le Gall E, Drenth JPH, Gansevoort RT, Harris PC, Harris T, Horie S, Liebau MC, Liew M, Mallett AJ, Mei C, Mekahli D, Odland D, Ong ACM, Onuchic LF, Pei YPC, Perrone RD, Rangan GK, Rayner B, Torra R, Mustafa R, Torres VE.: KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Kidney Int 107(2S): S1-S239, Feb 2025.

Torres VE, Ahn C, Barten TRM, Brosnahan G, Cadnapaphornchai MA, Chapman AB, Cornec-Le Gall E, Drenth JPH, Gansevoort RT, Harris PC, Harris T, Horie S, Liebau MC, Liew M, Mallett AJ, Changlin M, Mekahli D, Odland D, Ong ACM, Onuchic LF, Pei YPC, Perrone RD, Rangan GK, Rayner B, Torra R, Balk EM, Gordon CE, Earley A, Mustafa RA, Devuyst O: KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary. Kidney Int 107(2): 234-254, Feb 2025.

Lin K, Willieb-Weber C, Matesanz S, Cadnapaphornchai M, Lamberti M, Brandsema J, George L, Samuelson-Jones B: Conservative management of acute myocarditis and thrombotic microangiopathy after Elevidys (delandistrogene moxeparvovec). Oral Presentation, American Society of Gene + Cell Therapy (ASGCT) 28th Annual Meeting, New Orleans, LA 2025.

Gitomer BY, Ostrow A, Wang W, George D, Coleman E, Nowak KL, Cadnapaphornchai MA, Patel NU, Jovanowich A, Klawitter J, Farmer B, Chonchol M : Effect of pravastatin on kidney disease outcomes in adult patients with early-stage autosomal dominant polycystic kidney disease. Kidney Int 2025 Notes: in press (09/2025).

Klawitter J, Kirkpatrick B, Schillingburg R, Klawitter J, Wheeler G, Shokati T, Cadnapaphornchai MA, Galinkin JL, Thurman JM, Christians U: Monitoring of allograft adaptation after kidney transplantation in pediatric patients by targeted plasma metabolomics. Int J Molec Sci 2025 Notes: in press (09/2025).

Mekahli D, Guay-Woodford LM, Cadnapaphornchai MA, Goldstein SL, Dandurand A, Jiang H, Jadhav P, Debuque L.: Estimating risk of rapid disease progression in pediatric patients with autosomal dominant polycystic kidney disease: a randomized trial of tolvaptan. Pediatr Nephrol 2024.

Gitomer BY, Wang W, George D, Coleman E, Nowak KL, Struemph T, Cadnapaphornchai MA, Patel NU, Jovanovich A, Klawitter J, Farmer B, Ostrow A, You Z, Chonchol M.: Statin therapy in patients with early-stage autosomal dominant polycystic kidney disease: Design and baseline characteristics. Contemp Clin Trials 2024.

Michelle N Rheault, Charles E Alpers, Jonathan Barratt, Stewart Bieler, Pietro Canetta, Dong-Wan Chae, Gaia Coppock, Ulysses Diva, Loreto Gesualdo, Hiddo J L Heerspink, Jula K Inrig, Gianna M Kirsztajn, Donald Kohan, Radko Komers, Laura A Kooienga, Kenneth Lieberman, Alex Mercer, Irene L Noronha, Vlado Perkovic, Jai Radhakrishnan, William Rote, Brad Rovin, Vladimir Tesar, Hernán Trimarchi, James Tumlin, Muh Geot Wong, Howard Trachtman; DUPRO Steering Committee and DUPLEX Investigators: Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis. N Engl J Med 389(26): 2436-2445, Dec 2023.